Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2019-07-14 16:37:31 UTC |
---|
Last Updated | 2019-10-01 21:41:41 UTC |
---|
CypComp ID | CC02227 |
---|
Compound Information |
---|
Name | 58C80 |
---|
Structure Image | |
---|
InChIKey | NWCVRXADYNRXCT-JOCQHMNTSA-N |
---|
PubChem ID | Not Available |
---|
CypCompound Information |
---|
Set | CypBoM Training Set |
---|
Bonds of Metabolism (BoMs) | CYP1A2 | CYP2A6 | CYP2B6 | CYP2C8 | CYP2C9 | CYP2C19 | CYP2D6 | CYP2E1 | CYP3A4 | | | | | - <21,H;Hydroxylation;R1>
- <22,H;Hydroxylation;R2>
- <23,H;Hydroxylation;R3>
| | | | |
|
---|
References | - Weaver RJ, Dickins M, Burke MD: Cytochrome P450 2C9 is responsible for hydroxylation of the naphthoquinone antimalarial drug 58C80 in human liver. Biochem Pharmacol. 1993 Oct 5;46(7):1183-97. doi: 10.1016/0006-2952(93)90467-b. [PubMed:8216369 ]
|
---|
Download File | CC02227.sdf |
---|